Autogenous vaccine therapy for condyloma acuminatum. A double-blind controlled study.

Published

Journal Article

In an attempt to substantiate claims that autogenous vaccine is an effective form of immunotherapy for condyloma acuminatum, a double-blind cross-over study was carried out on 34 patients, in which autogenous wart vaccine was compared with a placebo vaccine identically prepared from each patient's own normal skin. It was found that the duration of disease was an important determinant of curability in patients with condylomata acuminata (P less than 0.001) and that when this factor was taken into account autogenous wart vaccine was not significantly more effective than the placebo (P = 0.43).

Full Text

Cited Authors

  • Malison, MD; Morris, R; Jones, LW

Published Date

  • February 1, 1982

Published In

Volume / Issue

  • 58 / 1

Start / End Page

  • 62 - 65

PubMed ID

  • 7034861

Pubmed Central ID

  • 7034861

International Standard Serial Number (ISSN)

  • 0007-134X

Digital Object Identifier (DOI)

  • 10.1136/sti.58.1.62

Language

  • eng